These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. FDG PET in early stage cutaneous malignant melanoma. McIvor J; Siew T; Campbell A; McCarthy M J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243 [TBL] [Abstract][Full Text] [Related]
9. The value of lymph node ultrasound and whole body Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826 [TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose-PET in the management of malignant melanoma. Kumar R; Mavi A; Bural G; Alavi A Radiol Clin North Am; 2005 Jan; 43(1):23-33. PubMed ID: 15693645 [TBL] [Abstract][Full Text] [Related]
11. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Uren RF; Thompson JF; Howman-Giles R; Chung DK Surg Oncol Clin N Am; 2006 Apr; 15(2):285-300. PubMed ID: 16632215 [TBL] [Abstract][Full Text] [Related]
12. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up. Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802 [TBL] [Abstract][Full Text] [Related]
13. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma. Kumar R; Alavi A Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921 [TBL] [Abstract][Full Text] [Related]
14. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133 [TBL] [Abstract][Full Text] [Related]
15. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Clark PB; Soo V; Kraas J; Shen P; Levine EA Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694 [TBL] [Abstract][Full Text] [Related]
16. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Thompson JF Ann Surg Oncol; 2001 Oct; 8(9 Suppl):44S-47S. PubMed ID: 11599898 [TBL] [Abstract][Full Text] [Related]
17. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study. Klein M; Freedman N; Lotem M; Marciano R; Moshe S; Gimon Z; Chisin R Nuklearmedizin; 2000; 39(3):56-61. PubMed ID: 10834191 [TBL] [Abstract][Full Text] [Related]